The Advertising Standards Authority (ASA) has upheld a decision to ban a clinic’s marketing materials advertising injectable vitamin D and vitamin B12.
Allergan recently unveiled new data from a multicenter, randomised, double-blind trial that showed 20 Units of VISTABEL® was as effective as 30 Units of Bocouture® for the treatment of moderate to severe glabellar lines. The study results were presented during the 7th European Masters in Anti-Ageing Medicine (EMAA) congress in Paris. “This new study underlines why it is important that medical aesthetic practitioners are aware of the differences between each of the botulinum toxins when selecting the most appropriate treatment for their patients,” comments Dr Moers-Carpi from Munich, Germany and lead investigator for the study. “With botulinum toxin manufacturers each having unique definitions of a unit, aesthetic practitioners should be vigilant in adopting the treatment protocol set by the respective manufacturer and not translating previous experience with one toxin to another.”
Aesthetic product supplier 4T Medical is offering two new training courses for botulinum toxin and dermal filler treatments.
Global pharmaceutical company Allergan has announced plans to invest more than €42 million (over £36 million) in an expansion.
The Advertising Standards Authority (ASA) has investigated a website and paid-for Google ad for Red Light Therapy.
Pharmaceutical company Galderma has released the results of its two phase III studies for its liquid formulation of botulinumtoxinA (relabotulinumtoxinA).
The Advertising Standards Authority (ASA) has upheld its decision for skincare supplement brand Dermacoll to revoke marketing claims in regards to a collagen drink it was promoting on its website.
The Joint Council for Cosmetic Practitioners (JCCP) has announced a national survey looking into patients’ experiences of botulinum toxin complications in the UK.
Pharmaceutical company Galderma is hosting a launch event for its new liquid neuromodulator Alluzience.
The British College of Aesthetic Medicine (BCAM) has revealed the results of the 2021 Annual Clinical Review